BACKGROUND: In cardiac patients positive affect has found to be associated with improved clinical outcomes, with reduced inflammation being one of the potential mechanisms responsible. METHODS: Positive affect was assessed using The Global Mood Scale (GMS), Positive and Negative Affect Schedule (PANAS), and Hospital Anxiety and Depression Scale (HADS) in patient with chronic heart failure (N=210; 67 ± 9 years, 79% men). Markers of inflammation (TNFα, sTNFr1, sTNFr2, IL-6 and CRP) were measured and averaged at three consecutive time points. RESULTS: The positive affect dimensions of the GMS and PANAS were significantly associated with lower averaged levels of sTNFr2, TNFα and IL-6 (p<.1), even after adjustment for clinical and lifestyle confounders. Positive affect of the HADS was significantly associated with lower averaged levels of hsCRP (p<.1), but was no longer significant after correction for lifestyle confounders and depressive symptoms. CONCLUSION: Positive affect is associated with reduced inflammation in patients with heart failure.
BACKGROUND: In cardiac patients positive affect has found to be associated with improved clinical outcomes, with reduced inflammation being one of the potential mechanisms responsible. METHODS: Positive affect was assessed using The Global Mood Scale (GMS), Positive and Negative Affect Schedule (PANAS), and Hospital Anxiety and Depression Scale (HADS) in patient with chronic heart failure (N=210; 67 ± 9 years, 79% men). Markers of inflammation (TNFα, sTNFr1, sTNFr2, IL-6 and CRP) were measured and averaged at three consecutive time points. RESULTS: The positive affect dimensions of the GMS and PANAS were significantly associated with lower averaged levels of sTNFr2, TNFα and IL-6 (p<.1), even after adjustment for clinical and lifestyle confounders. Positive affect of the HADS was significantly associated with lower averaged levels of hsCRP (p<.1), but was no longer significant after correction for lifestyle confounders and depressive symptoms. CONCLUSION: Positive affect is associated with reduced inflammation in patients with heart failure.
Authors: Jeff C Huffman; Rachel A Millstein; Carol A Mastromauro; Shannon V Moore; Christopher M Celano; C Andres Bedoya; Laura Suarez; Julia K Boehm; James L Januzzi Journal: J Happiness Stud Date: 2015-10-19
Authors: Christina M DuBois; Oriana Vesga Lopez; Eleanor E Beale; Brian C Healy; Julia K Boehm; Jeff C Huffman Journal: Int J Cardiol Date: 2015-05-21 Impact factor: 4.164
Authors: Christopher M Celano; Melanie E Freedman; Lauren E Harnedy; Elyse R Park; James L Januzzi; Brian C Healy; Jeff C Huffman Journal: J Psychosom Res Date: 2020-10-29 Impact factor: 3.006
Authors: Jessica J Chiang; Julienne E Bower; David M Almeida; Michael R Irwin; Teresa E Seeman; Andrew J Fuligni Journal: Psychosom Med Date: 2015-04 Impact factor: 4.312
Authors: Rachel A Millstein; Wei-Jean Chung; Bettina B Hoeppner; Julia K Boehm; Sean R Legler; Carol A Mastromauro; Jeff C Huffman Journal: Gen Hosp Psychiatry Date: 2019-04-04 Impact factor: 3.238
Authors: Christopher M Celano; Melanie E Freedman; Eleanor E Beale; Federico Gomez-Bernal; Jeff C Huffman Journal: J Nerv Ment Dis Date: 2018-10 Impact factor: 2.254
Authors: Christopher M Celano; Eleanor E Beale; Shannon V Moore; Deborah J Wexler; Jeff C Huffman Journal: Curr Diab Rep Date: 2013-12 Impact factor: 4.810
Authors: Gholam Reza Nikrahan; Laura Suarez; Karim Asgari; Scott R Beach; Christopher M Celano; Mehrdad Kalantari; Mohammad Reza Abedi; Ali Etesampour; Rezaei Abbas; Jeff C Huffman Journal: Psychosomatics Date: 2016-03-08 Impact factor: 2.386